Katie MacFarlane Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Katie MacFarlane.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Katie MacFarlane. Katie MacFarlane is Director in RespireRx Pharmaceuticals Inc. ($RSPI) and Chief Commercial Officer in AGILE THERAPEUTICS INC ($AGRX).
Latest Insider Trading Transactions of Katie MacFarlane
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.01 | 5,000,000 | 27,000 | 5,000,000 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.01 | 5,000,000 | 27,000 | 5,000,000 | |
| Aug 04 2020 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.01 | 7,500,000 | 54,000 | 7,500,000 | |
| Dec 12 2017 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | J | 1.45 | 38,114 | 55,265 | 38,114 | |
| Jul 05 2017 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 2.00 | 25,000 | 50,000 | 25,000 | |
| Jan 20 2017 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 3.90 | 25,000 | 97,500 | 25,000 | |
| Apr 04 2016 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.02 | 10,000,000 | 227,000 | 10,000,000 | |
| Feb 10 2016 | AGRX | AGILE THERAPEUTICS ... | MacFarlane Katie | Chief Commercial Of ... | Option Exercise | A | 5.93 | 35,000 | 207,550 | 35,000 | |
| Aug 20 2015 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.02 | 3,000,000 | 59,100 | 3,000,000 | |
| Jul 02 2015 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.03 | 2,000,000 | 50,000 | 2,000,000 | |
| Feb 23 2015 | AGRX | AGILE THERAPEUTICS ... | MacFarlane Katie | Chief Commercial Of ... | Option Exercise | A | 9.45 | 21,000 | 198,450 | 21,000 |
Page: 1